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Abstract Affective symptoms, such as depression and
apathy, and cognitive dysfunction, such as psychomotor
slowness, are known to have negative impacts on the
quality of life (QOL) of patients with mental and physical
diseases. However, the relationships among depressive
symptoms, apathy, psychomotor slowness, and QOL in a
non-clinical population are unclear. The aim of the present
study was to assess these relationships and examine the
underlying cortical mechanisms in a non-clinical popula-
tion. Fifty-two healthy male volunteers were assessed for
depressive symptoms using the Zung Self-rating Depres-
sion Scale (SDS), for apathy measured using the Apathy
Scale, and QOL using the Short-Form 36 item question-
naire (SF36). The volunteers also performed the Trail
Making Test Part A (TMT-A) while undergoing assess-
ment of hemoglobin concentration changes in the frontal
cortical surface using 24-channel near-infrared spectros-
copy (NIRS). The scores of the SDS and Apathy Scale
showed significant negative correlations with the scores of
most of subscales of the SF36. In addition, the SDS score
had a significant positive correlation with the time to
complete the TMT-A. Further, activation of several frontal
cortical areas had a significant positive correlation with the
scores of the SDS and Apathy Scale. These results suggest
that the degree of depressive symptoms and apathy are
associated with a lower QOL in a non-clinical population
and that cortical hyperactivation during a psychomotor
task measured by NIRS may identify objectively individ-
uals with a high degree of depressive symptoms and
apathy.
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Introduction
Depressive symptoms and apathy have major impacts on
the mental and physical health of individuals. Major
depressive disorder (MDD), for example, is characterized
by depressive symptoms and loss of interest, which is a
component of apathy, and is a leading cause of worldwide
disability. Worsening of depressive symptoms is associated
with a reduced quality of life (QOL) [7, 17, 31]. The
presence of subsyndromal depressive symptoms has also
been shown to have a negative impact on psychosocial
functioning [9]. In addition, there is increasing evidence
that depressive symptoms are influential in the onset or
progression of various kinds of diseases including Alz-
heimer’s disease [25], coronary disease [11], and diabetes
[1]. Furthermore, there is substantial evidence suggesting
the negative impacts of depressive symptoms and apathy
on QOL in many diseases including HIV [33], Parkinson’s
disease [21, 29], and brain tumors [14].
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In addition to depressive symptoms and apathy, cogni-
tive decline such as psychomotor slowness has a negative
impact on social functioning of individuals. For example,
Naismith et al. [20] reported that objectively measured
psychomotor slowness is a significant predictor of physical
disability in MDD, and Muslimovic et al. [19] reported that
psychomotor slowness has a negative effect on QOL in
Parkinson’s disease. The Trail Making Test (TMT) is a
popular neuropsychological instrument and is presumed to
be a test of psychomotor skills [12, 27]. Functional neu-
roimaging studies have reported the involvement of the
frontal cortical network in TMT [10, 18, 30, 40].
Meanwhile, neurocircuit abnormalities, an underlying
condition in depressive symptoms and apathy in MDD,
have been studied using neuroimaging approaches. For
example, previous studies reported that anhedonic symp-
toms and depression severity were associated with reduced
caudate volume [26] and decreased activation in the sub-
genual anterior cingulate cortex [16]. In addition, there is
substantial evidence suggesting that psychomotor slowness
in MDD is related to the fronto-striatal circuitry. Several
studies using positron emission tomography (PET) reported
that MDD patients with affective flattening and psycho-
motor slowness had decreased presynaptic dopamine
function in the left caudate [2, 15].
In contrast to overt psychopathology such as MDD,
there have been few studies that have examined the rela-
tionship among depressive symptoms, apathy and psycho-
motor slowness in a non-clinical population, and the
cortical mechanisms of such symptomatology are unclear.
Recently, the development of near-infrared spectroscopy
(NIRS) has enabled non-invasive measurement of cortical
activation under natural conditions, which enables exami-
nation while the subject performs a task related to psy-
chomotor slowness such as the TMT-A. We hypothesized
that the degree of depressive symptoms and apathy are
associated with psychomotor slowness, as measured by
TMT-A, and abnormal cortical activation, as measured by
NIRS, as well as low QOL in a non-clinical population. We




Fifty-two healthy male volunteers participated in this study
(mean age, 37.4 ± 11.1 years). All subjects were deter-
mined to be right-handed using the Edinburgh Handedness
Inventory scale [24]. Two experienced psychiatrists toge-
ther excluded a participant with psychiatric symptoms
above the threshold level. No subject had a history of major
psychiatric disorder including major depressive disorder
and anxiety disorder, neurological disorder, substance
abuse, head injury, or major physical illness or was using
any psychotropic medications at the time of the study. This
study was approved by the Institutional Review Board of
Mihara Hospital and the Prefectural University of Hiro-
shima. Written informed consent was obtained from each
subject prior to the study.
Assessment of depressive symptoms, apathy, and QOL
Each subject was assessed for subjective depressive
symptoms, extent of apathy, and QOL.
Subjective depressive symptoms were measured using
the Zung Self-rating Depression Scale (SDS), a self-rating
scale that consists of 20 questionnaires. The score of the
SDS ranges from 20 (best) to 80 (worst), and the average is
35.1 ± 8.0 (mean ± SD) in the Japanese normal control
population [5]. A higher score of the SDS is an indicative
of a relatively greater degree of depressive symptoms.
Extent of apathy was measured using the Apathy Scale,
a self-rating scale for assessing a tendency of apathy that
consists of 16 questionnaires. The score of the Apathy
Scale ranges from 0 (best) to 42 (worst), and the average is
8.7 ± 6.6 (mean ± SD) in the Japanese normal control
population [23]. A higher score of the scale is an indicative
of a relatively greater degree of apathy.
QOL was measured using the Medical Outcomes Study
Short-Form 36-item questionnaire (SF36) [39]. SF36 is
used widely to assess physical and mental well-being in
social and individual contexts. Eight subscales are
derived, referring to 8 health concepts: physical func-
tioning (SF36-PF), role functioning-physical (SF36-RP),
bodily pain (SF36-BP), general health (SF36-GH), vitality
(SF36-VT), social functioning (SF36-SF), role function-
ing-emotional (SF36-RE), and mental health (SF36-MH).
Each subscale ranges from 0 (worst health) to 100 (best
health), and a score of 50 represents the mean score for
the population.
Activation task
The activation task consisted of a 30-s pre-task baseline, a
TMT-A, and a 70-s post-task baseline. Each subject sat on
a comfortable chair in a quiet room, and the subject was
ordered to keep their head immobile as much as possible
and to not speak. During the test, the subjects were required
to draw a line as rapidly as possible joining consecutive
numbers (1–25), which were pseudorandomly arranged on
each page. We used series of 4 TMT-A sheets, which had
different circle position patterns. The time required for
completing the test (TMT time) was determined as a
measure of task performance. During the pre-task and
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post-task periods, the subjects were instructed to draw lines
repeatedly between two spots on a paper.
NIRS measurement
In this study, changes in [oxy-Hb] and [deoxy-Hb] were
measured using a 24-channel NIRS machine (Hitachi ETG-
100) at two wavelengths of near-infrared light (i.e., 780 and
830 nm). Absorption was measured, and [oxy-Hb] and
[deoxy-Hb] were calculated. The distance between the pair
of emission and detector probes was 3.0 cm, and it was
considered that the machine could measure points at a depth
of 2–3 cm from the scalp, that is, the surface of the cerebral
cortex [8, 35]. As shown in Fig. 1, the probes of the NIRS
machine were placed on the subject’s bilateral frontal
region. The frontal probes measured hemoglobin concen-
tration changes at 24 measurement points in a 6 ± 15 cm
area, with the lowest probes positioned along the Fp1–Fp2
line according to the international 10/20 system used in
electroencephalography. The absorption of near-infrared
light was measured with a time resolution of 0.1 s. The
obtained data were analyzed using the ‘‘integral mode’’.
The pre-task baseline was determined as the mean across
the last 10 s of the 30-s pre-task period, and the post-task
baseline was determined as the mean across the last 5 s of
the 70-s post-task period. Linear fitting was applied to the
data between these two baselines. The moving average
method was used to exclude short-term motion artifacts in
the analyzed data (moving average window: 5 s).
Data analyses
The analysis focused on [oxy-Hb] changes. Changes in
[oxy-Hb] were assumed to more directly reflect cognitive
activation than [deoxy-Hb] changes, as shown by a
stronger correlation with blood-oxygenation level-depen-
dent (BOLD) signals measured by fMRI [32].
NIRS data that clearly contained motion artifacts
determined by a close observation of the subjects were
excluded from analyses.
To examine the relationship among affective symptoms
(SDS, Apathy Scale) and QOL (SF36), task performances
(TMT time) and [oxyHb] changes during TMT, Pearson
correlation analyses were conducted.
Statistical analysis was performed using PASW 18.0
software (Tokyo, Japan).
Results
Correlation between affective symptoms and QOL
Averaged scores of the SDS, Apathy Scale, and SF-36 are
shown in Table 1. As shown in Table 2, the SDS nega-
tively correlated with the SF36-RP (r = -0.285, p =
0.041), SF36-BP (r = -0.279, p = 0.045), SF36-GH (r =
-0.574, p \ 0.001), SF36-VT (r = -0.635, p \ 0.001),
SF36-RE (r = -0.434, p = 0.002), and SF36-MH (r =
-0.640, p \ 0.001). The Apathy Scale negatively corre-
lated with the SF36-PF (r = -0.367, p = 0.007), SF36-
GH (r = -0.316, p = 0.023), SF36-VT (r = -0.459,
p = 0.001), SF36-RE (r = -0.413, p = 0.002), and SF36-
MH (r = -0.433, p = 0.001). These results suggest that
depressive symptoms and apathy are closely related to a
lower QOL.
Correlation between affective symptoms and task
performance
The average TMT time was 75.4 ± 18.3 (mean ± SD)


















Fig. 1 Probe setting and channels showing significant correlations
with the SDS and Apathy Scale. Yellow area indicates a channel
showing significant correlations with the SDS. Blue areas indicate
channels showing significant correlations with the Apathy Scale.
Green areas indicate channels showing significant correlations with
both the SDS and Apathy Scale
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with TMT time (r = 0.357, p = 0.009), suggesting that
participants with depression took a longer time to complete
the task. In contrast, there was no significant correlation
between the score of the Apathy Scale and TMT time
(r = 0.261, p = 0.062).
Correlation between affective symptoms and [oxy-Hb]
changes during task
As shown in Table 3 and Fig. 1, [oxy-Hb] changes during
the TMT-A was positively correlated with SDS in CH2
(r = 0.442, p = 0.021), CH13 (r = 0.400, p = 0.013),
and CH15 (r = 0.528, p = 0.006) and with Apathy Scale
in CH5 (r = 0.451, p = 0.046), CH13 (r = 0.372, p =
0.021), CH15 (r = 0.0.711, p \ 0.001), CH22(r = 0.339,
p = 0.017), and CH24(r = 0.361, p = 0.009). No channel
showed [oxy-Hb] changes during the TMT-A that were
negatively correlated with the SDS or the Apathy Scale.
These results suggest that participants with depression and
apathy required greater levels of functional activation in
several brain areas to complete the task.
Discussion
In this study, we demonstrated that depressive symptoms
and apathy negatively affect brain function and QOL in a
non-clinical population. An unexpected, but interesting
result was that depressive symptoms had a greater negative
impact on task performance than apathy. In this study, we
showed that the score of the SDS was positively correlated
with the TMT time, but the degree of apathy was not
correlated with the TMT time. We also showed that par-
ticipants with a high degree of depressive symptoms and
apathy had a greater [oxy-Hb] increase in many frontal
cortical regions.
Table 1 Affective symptoms and QOL
Mean SD
SDS 36.8 7.7









SD standard deviation, SDS Zung Self-rating Depression Scale, SF36
Medical Outcomes Study Short-Form 36-item questionnaire, PF
physical functioning, RP role functioning, BP bodily pain, GH gen-
eral health, VT vitality, SF social functioning, RE role emotional, MH
mental health











SDS Zung Self-rating Depression Scale, SF36 Medical Outcomes
Study Short-Form 36-item questionnaire, PF physical functioning, RP
role functioning, BP bodily pain, GH general health, VT vitality, SF
social functioning, RE role emotional, MH mental health
* p \ 0.05; ** p \ 0.01
Table 3 Correlation coefficients between affective symptoms and
[oxy-Hb] changes during TMT

























SDS Zung Self-rating Depression Scale
* p \ 0.05; ** p \ 0.01
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The degree of depressive symptoms and apathy were
associated with most of indices of the SF-36. Our results
are consistent with those reported by McCall et al. [17],
who showed that an increasing severity of depression was
associated consistently with worse QOL in MDD. Our
results are also consistent with those of Oguru et al. [21],
who reported that both the Apathy Scale and Beck
Depression Inventory scores were negatively correlated
with QOL in Parkinson’s disease. Together, our results
suggest that the presence of depressive symptoms and
apathy has a negative impact on individual QOL.
The degree of depressive symptoms was associated
significantly with psychomotor slowness, but the degree
of apathy was not related to psychomotor slowness. The
relationship between psychomotor slowness and age has
been shown in previous studies [3, 34]. In our study, age
was positively correlated with the TMT time, but there
was no correlation between age and affective symptoms
(data not shown). Psychomotor slowness in MDD has
been shown in previous studies. For example, slower
response times in MDD were observed on the TMT, Rule
Shift Cards, and Stroop test [6]. Our results are consistent
with those reported by Rosenberg et al. [28], who showed
that the Geriatric Depression Scale was associated with
incident impairment on all cognitive tests including the
TMT-A in healthy older women. However, our results are
inconsistent with those reported by Feli et al. [4], who
showed that apathy correlated with a measure of infor-
mation processing speed (Stroop test B) in older MDD
patients. The reason for this inconsistency is unclear, but
one possible reason is a difference between the tasks for
psychomotor slowness. The TMT-A may not be suffi-
ciently sensitive to detect the effects of apathy on brain
function.
We also showed that participants with high degree of
depressive symptoms and apathy had a greater [oxy-Hb]
increase in many frontal cortical regions. Previous neu-
roimaging studies on cognitive impairment in MDD have
demonstrated brain activation patterns with hypo-(e.g.,
Okada et al. [22]) and hyper-(e.g., Walter et al. [38])
activation of frontal cortical regions [13, 37]. In such
studies, performance must be taken into account before
attempting interpretation, and hyperactivation in context
of equal or poorer performance is usually interpreted as
‘inefficiency’. In this study, we found hyperactivation in
the context of equal or poorer performance with a high
degree of depressive symptoms and apathy, that is, inef-
ficiency. Our results are consistent with those of Wagner
et al. [36], who reported prefrontal hyperactivation with
equal performance of the Stroop test in MDD using fMRI,
and with results of Walter et al. [38], who reported that
prefrontal hyperactivation with poor performance of
Working Memory task in MDD using fMRI. Our results
suggest that participants with a high degree of depressive
symptoms and apathy require greater cortical resources to
perform the same task. Furthermore, lower QOL and
psychomotor slowness caused by depressive symptoms
and apathy may be related to such inefficient frontal
activation.
Our results are inconsistent with our hypothesis. We
found that apathy was associated with low QOL and frontal
cortical inefficiency, but was not correlated with psycho-
motor slowness. One potential explanation is that the
effects of apathy may be more sensitively measured by
cortical [oxy-Hb] changes detected by NIRS than by
behavioral output. Thus, our present methods combining
behavioral and NIRS measurement enabled us to detect the
effects of apathy on brain function that would be difficult to
detect by behavioral output alone.
There are several limitations in this study that should be
taken into consideration. First, the participants were all
male because women can have potentially influential factor
such as mood fluctuations across the menstrual cycle, and
our findings may not be generalizable to a female popu-
lation. Second, assessments of depressive symptoms and
apathy are based on self-rating scales without a structured
diagnostic interview (e.g., SCID). Third, age and IQ were
not controlled. They are potential factors capable of
affecting not only psychomotor slowness, but also brain
function and QOL. Fourth, depressive symptom was
measured using the SDS. Although the SDS was developed
specifically for patients with a diagnosis of major depres-
sion, the SDS is commonly used even in healthy subject
study, since the scale is simple and less burdensome for
subjects. Fifth, power analysis and multiple comparisons
were not conducted in our study as in most previous NIRS
studies. Further studies should take these factors into
account. With these limitations in mind, this study provides
evidence to support the hypothesis that depressive symp-
toms and apathy were associated with psychomotor slow-
ness and abnormal cortical activation, as well as low QOL
in a non-clinical population.
In conclusion, the degree of depressive symptoms and
apathy were associated with lower QOL, and participants
with high degree of depressive symptoms and apathy have
inefficient cortical activations. On the basis of the findings,
we assume that cortical hyperactivation during a psycho-
motor task measured by NIRS may be used to identify
objectively individuals with a high degree of depressive
symptoms and apathy. Further functional neuroimaging
studies focusing on depressive symptoms and apathy at a
non-clinical level may elucidate the brain mechanisms
underlying depressive symptoms and apathy. These studies
may be beneficial for promoting the QOL of healthy sub-
jects and patients suffering from depressive symptoms and
apathy.
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